Feb 13 (Reuters) - Evolus EOLS.O said on Thursday the U.S. Food and Drug Administration has approved its two new anti-wrinkle injectable gels, expanding the company's product portfolio beyond its cosmetic injection Jeuveau.
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.